BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 9199241)

  • 1. A new functional isoform of the human CRF2 receptor for corticotropin-releasing factor.
    Valdenaire O; Giller T; Breu V; Gottowik J; Kilpatrick G
    Biochim Biophys Acta; 1997 May; 1352(2):129-32. PubMed ID: 9199241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cloning and functional expression of the mouse CRF2(a) receptor splice variant.
    Dautzenberg FM; Higelin J; Wille S; Brauns O
    Regul Pept; 2004 Sep; 121(1-3):89-97. PubMed ID: 15256278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A soluble form of the first extracellular domain of mouse type 2beta corticotropin-releasing factor receptor reveals differential ligand specificity.
    Perrin MH; DiGruccio MR; Koerber SC; Rivier JE; Kunitake KS; Bain DL; Fischer WH; Vale WW
    J Biol Chem; 2003 May; 278(18):15595-600. PubMed ID: 12611895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the abundant expression of arginine 185 containing human CRF(2alpha) receptors and the role of position 185 for receptor-ligand selectivity.
    Dautzenberg FM; Huber G; Higelin J; Py-Lang G; Kilpatrick GJ
    Neuropharmacology; 2000 Jun; 39(8):1368-76. PubMed ID: 10818253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
    Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB
    Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and functional pharmacology of two corticotropin-releasing factor receptors from a teleost fish.
    Pohl S; Darlison MG; Clarke WC; Lederis K; Richter D
    Eur J Pharmacol; 2001 Nov; 430(2-3):193-202. PubMed ID: 11711031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.
    Lewis K; Li C; Perrin MH; Blount A; Kunitake K; Donaldson C; Vaughan J; Reyes TM; Gulyas J; Fischer W; Bilezikjian L; Rivier J; Sawchenko PE; Vale WW
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7570-5. PubMed ID: 11416224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
    Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
    Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism.
    Dautzenberg FM; Wille S
    Regul Pept; 2004 May; 118(3):165-73. PubMed ID: 15003833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that corticotropin-releasing factor receptor type 1 couples to Gs- and Gi-proteins through different conformations of its J-domain.
    Berger H; Heinrich N; Wietfeld D; Bienert M; Beyermann M
    Br J Pharmacol; 2006 Dec; 149(7):942-7. PubMed ID: 17057757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.
    Hoare SR; Sullivan SK; Fan J; Khongsaly K; Grigoriadis DE
    Peptides; 2005 Mar; 26(3):457-70. PubMed ID: 15652653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ligand-selective domains of corticotropin-releasing factor type 1 and type 2 receptor reside in different extracellular domains: generation of chimeric receptors with a novel ligand-selective profile.
    Dautzenberg FM; Kilpatrick GJ; Wille S; Hauger RL
    J Neurochem; 1999 Aug; 73(2):821-9. PubMed ID: 10428081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of agonist- and antagonist-binding domains of human corticotropin-releasing factor receptors.
    Liaw CW; Grigoriadis DE; Lorang MT; De Souza EB; Maki RA
    Mol Endocrinol; 1997 Dec; 11(13):2048-53. PubMed ID: 9415408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urocortin is the principal ligand for the corticotrophin-releasing factor binding protein in the ovine brain with no evidence for a sauvagine-like peptide.
    Baigent SM; Lowry PJ
    J Mol Endocrinol; 2000 Feb; 24(1):53-63. PubMed ID: 10656997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human CRF2 alpha and beta splice variants: pharmacological characterization using radioligand binding and a luciferase gene expression assay.
    Ardati A; Goetschy V; Gottowick J; Henriot S; Valdenaire O; Deuschle U; Kilpatrick GJ
    Neuropharmacology; 1999 Mar; 38(3):441-8. PubMed ID: 10219982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.
    Lovenberg TW; Liaw CW; Grigoriadis DE; Clevenger W; Chalmers DT; De Souza EB; Oltersdorf T
    Proc Natl Acad Sci U S A; 1995 Jan; 92(3):836-40. PubMed ID: 7846062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2gamma receptor.
    Kostich WA; Chen A; Sperle K; Largent BL
    Mol Endocrinol; 1998 Aug; 12(8):1077-85. PubMed ID: 9717834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain.
    Primus RJ; Yevich E; Baltazar C; Gallager DW
    Neuropsychopharmacology; 1997 Nov; 17(5):308-16. PubMed ID: 9348546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing factor receptors and urocortins, links between the brain and the heart.
    Yang LZ; Tovote P; Rayner M; Kockskämper J; Pieske B; Spiess J
    Eur J Pharmacol; 2010 Apr; 632(1-3):1-6. PubMed ID: 20132811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An artificial peptide with corticotropin-releasing factor receptor-2 (CRF-R2) selective properties: the role of primary structure in the induction of signal transduction pathways.
    Tellam DJ; Smart D; Qian X; Lovejoy DA
    J Pept Res; 2002 Oct; 60(4):215-22. PubMed ID: 12366528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.